• Must be submitted in English;
• Must be original and not previously published;
• Make sure the size of the abstract is approximately 3 000 characters;
• Structure your abstract using:
  • Introduction and objectives;
  • Materials and methods;
  • Results;
  • Conclusions.
• Structure your case report using:
  • Introduction;
  • Case presentation;
  • Conclusions.
• The use of commercial drug names, brands and registered trademarks are not allowed. Drugs should be referred to by the active substance;
• Please attach the abstract as a document.

Deadline for abstract submission: 26 September 2022